Results 101 to 110 of about 5,353 (192)

MOESM5 of Unbiased phenotypic identification of functionally distinct hematopoietic progenitors

, 2019
Additional file 5: Figure S4. Time-course of CD123 expression during the ex-vivo erythroid development from adult human CD34+. Expression of CD123 is increased from day 6 and on along with the emergence of erythroid progenitors in the culture.
Minas Yiangou (246034), Jeff Vierstra (6998768), Nikoletta Psatha (6998765), Grigorios Georgolopoulos (3243450), Mineo Iwata (387073)   +4 more
core   +1 more source

Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34\u3csup\u3e+\u3c/sup\u3e cells mobilized by G-CSF and plerixafor [PDF]

, 2011
Objective. Granulocyte colony-stimulating factor (G-CSF) in combination with plerixafor produces significant mobilization of CD34+ cells in rhesus macaques.
Leitman, Susan F., Lee-Stroka, Agnes, Hsieh, Matthew M., Donahue, Robert E., Bonifacino, Aylin, Uchida, Naoya, Metzger, Mark E., Fasano, Ross M., Mattapallil, Joseph J., Csako, Gyorgy, Tisdale, John F., Krouse, Allen E.   +11 more
core  

Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2

, 2000
We found previously that Id3, which inhibits transcriptional activities of many basic helix-loop-helix transcription factors, blocked T and B cell development but stimulated natural killer (NK) cell development.
Couwenberg, F., Spits, H., Weijer, K., Bakker, A. Q., Uittenbogaart, C. H.   +4 more
core   +1 more source

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia

, 2023
Introduction: Acute myeloid leukaemia (AML) is a heterogeneous malignant disease with a high degree of treatment failure using chemotherapy. Leukaemia stem cells (LSCs) are CD34+CD38- early progenitors associated with poor prognosis in AML.
Cheong, SK, Panneerselvan, N, Mohd Amin, A, Abdullah, M, Mohtaruddin, N, Md Noor, S, Sathar, J, Osman, R, Kee, LH, Norbaya, WS, Mohd Yaaku, WH   +10 more
core   +1 more source

P028 | Flow cytometric characterization of myelodysplastic syndrome stem cells: a new prognostic tool

Haematologica
Introduction: Myelodysplastic Syndromes (MDS) are clonal hematopoietic disorders characterized by ineffective hematopoiesis, and high risk of transformation to Acute Myeloid Leukemia (AML).
Anna Sicuranza
doaj  

Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study

The Journal of Pathology: Clinical Research
Myeloid sarcoma (MS) is a tumorous extramedullary proliferation of blast or blast equivalent cells (e.g., promonocytes or promyelocytes). The most frequent cutaneous presentation is often referred to as leukemia cutis (LC).
Alex Jenei, Béla Kajtár, Tamás László, Hazem A Juratli, Livia Vida, Ágota Szepesi, Réka Mózes, Botond Timár, Jörg Halter, Stefan Dirnhofer, Alexandar Tzankov   +10 more
doaj   +1 more source

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions

Frontiers in Oncology
IntroductionThe decisive key to disease-free survival in B-cell precursor acute lymphoblastic leukemia in children, is the combination of diagnostic timeliness and treatment efficacy, guided by accurate patient risk stratification.
Rubí Romo-Rodríguez, Gabriela Zamora-Herrera, Gabriela Zamora-Herrera, Jebea A. López-Blanco, Lucero López-García, Arely Rosas-Cruz, Laura Alfaro-Hernández, Laura Alfaro-Hernández, César Omar Trejo-Pichardo, Dulce Rosario Alberto-Aguilar, Dulce Rosario Alberto-Aguilar, Diana Casique-Aguirre, Diana Casique-Aguirre, Armando Vilchis-Ordoñez, Armando Vilchis-Ordoñez, Juan Carlos Solis-Poblano, Lilia Adela García-Stivalet, Vanessa Terán-Cerqueda, Nuria Citlalli Luna-Silva, Miguel Ángel Garrido-Hernández, Lena Sarahí Cano-Cuapio, Karen Ayala-Contreras, Fabiola Domínguez, María de los Ángeles del Campo-Martínez, Gerardo Juárez-Avendaño, Juan Carlos Balandrán, Sonia Mayra Pérez-Tapia, Carlos Fernández-Giménez, Pedro A. Zárate-Rodríguez, Enrique López-Aguilar, Aurora Treviño-García, Célida Duque-Molina, Laura C. Bonifaz, Juan Carlos Núñez-Enríquez, Mariana Cárdenas-González, Elena R. Álvarez-Buylla, Dalia Ramírez-Ramírez, Rosana Pelayo, Rosana Pelayo   +38 more
doaj   +1 more source

Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation

, 2000
We characterized CD34+ cells purified from bone marrow (BM), mobilized peripheral blood (PB) and cord blood (CB) and we tried to establish correlations between the cell cycle kinetics of the CD34+CD38- and CD34+CD38+ subpopulations, their sensitivity to ...
Lagneaux, Laurence, Delforge, Alain, De Bruyn, Cécile, Bron, Dominique   +3 more
core   +1 more source

Erişkin akut miyeloid lösemide akım sitometrik minimal rezidüel hastalık takibi

, 2018
Akut miyeloid lösemi, genel olarak yaşlı bireylerde görülen malign bir hastalıktır. AML; hızlı başlar, hızlı ilerler ve hematopoetik sistemi blastik hücreler istila ederler. Tedavi sağlanmazsa, ölüme neden olabilecek bir karaktere sahiptir.
FATİH SERDAR ŞAHİN
core  

VPA treatment increases the absolute number of MEP.

, 2018
UCB-derived CD34+ cells were differentiated towards megakaryocytes for 4 days in the absence or presence of 200μM VPA, or 5mM NAM. Myeloid progenitor staining was performed according to Manz et al.
Marc Bierings (5146094), Ruben van Boxtel (105351), Michal Mokry (236330), Stephin Vervoort (5146097), Cornelieke Pals (5146100), Wouter van Solinge (569494), Roel Polak (5146103), Toine Egberts (3585644), Edward Nieuwenhuis (3499664), Marije Bartels (532852), Anita Govers (5146091), Paul James Coffer (5146106)   +11 more
core   +1 more source